121 related articles for article (PubMed ID: 33349227)
21. Plasma miR-601 and miR-760 are novel biomarkers for the early detection of colorectal cancer.
Wang Q; Huang Z; Ni S; Xiao X; Xu Q; Wang L; Huang D; Tan C; Sheng W; Du X
PLoS One; 2012; 7(9):e44398. PubMed ID: 22970209
[TBL] [Abstract][Full Text] [Related]
22. Extensive screening of microRNA populations identifies hsa-miR-375 and hsa-miR-133a-3p as selective markers for human rectal and colon cancer.
Weber D; Amar L; Gödde D; Prinz C
Oncotarget; 2018 Jun; 9(43):27256-27267. PubMed ID: 29930763
[TBL] [Abstract][Full Text] [Related]
23. microRNA-221 and microRNA-18a identification in stool as potential biomarkers for the non-invasive diagnosis of colorectal carcinoma.
Yau TO; Wu CW; Dong Y; Tang CM; Ng SS; Chan FK; Sung JJ; Yu J
Br J Cancer; 2014 Oct; 111(9):1765-71. PubMed ID: 25233396
[TBL] [Abstract][Full Text] [Related]
24. Combined Plasma MicroRNA and Fecal Occult Blood Tests in Early Detection of Colorectal Cancer.
Luo X; Wu Y; Ji M; Zhang S
Clin Lab; 2019 May; 65(5):. PubMed ID: 31115212
[TBL] [Abstract][Full Text] [Related]
25. Non-coding MicroRNAs hsa-let-7g and hsa-miR-181b are Associated with Chemoresponse to S-1 in Colon Cancer.
Nakajima G; Hayashi K; Xi Y; Kudo K; Uchida K; Takasaki K; Yamamoto M; Ju J
Cancer Genomics Proteomics; 2006 Oct; 3(5):317-324. PubMed ID: 18172508
[TBL] [Abstract][Full Text] [Related]
26. Plasma miR-200c and miR-18a as potential biomarkers for the detection of colorectal carcinoma.
Zhang GJ; Zhou T; Liu ZL; Tian HP; Xia SS
Mol Clin Oncol; 2013 Mar; 1(2):379-384. PubMed ID: 24649179
[TBL] [Abstract][Full Text] [Related]
27. Circular RNA circVAPA is up-regulated and exerts oncogenic properties by sponging miR-101 in colorectal cancer.
Li XN; Wang ZJ; Ye CX; Zhao BC; Huang XX; Yang L
Biomed Pharmacother; 2019 Apr; 112():108611. PubMed ID: 30797148
[TBL] [Abstract][Full Text] [Related]
28. Overexpression of miR-17 is correlated with liver metastasis in colorectal cancer.
Lai H; Zhang J; Zuo H; Liu H; Xu J; Feng Y; Lin Y; Mo X
Medicine (Baltimore); 2020 Feb; 99(9):e19265. PubMed ID: 32118734
[TBL] [Abstract][Full Text] [Related]
29. Identification and validation of potential biomarkers for the detection of dysregulated microRNA by qPCR in patients with colorectal adenocarcinoma.
Wu X; Xu X; Li S; Wu S; Chen R; Jiang Q; Liu H; Sun Y; Li Y; Xu Y
PLoS One; 2015; 10(3):e0120024. PubMed ID: 25803870
[TBL] [Abstract][Full Text] [Related]
30. Integrated analysis identifies microRNA-195 as a suppressor of Hippo-YAP pathway in colorectal cancer.
Sun M; Song H; Wang S; Zhang C; Zheng L; Chen F; Shi D; Chen Y; Yang C; Xiang Z; Liu Q; Wei C; Xiong B
J Hematol Oncol; 2017 Mar; 10(1):79. PubMed ID: 28356122
[TBL] [Abstract][Full Text] [Related]
31. Construction of endogenous RNA regulatory network for colorectal cancer based on bioinformatics.
Li Y; Yuan F; Lin Z; Pan Y
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Apr; 47(4):416-430. PubMed ID: 35545337
[TBL] [Abstract][Full Text] [Related]
32. A ten-microRNA signature identified from a genome-wide microRNA expression profiling in human epithelial ovarian cancer.
Wang L; Zhu MJ; Ren AM; Wu HF; Han WM; Tan RY; Tu RQ
PLoS One; 2014; 9(5):e96472. PubMed ID: 24816756
[TBL] [Abstract][Full Text] [Related]
33. Comprehensive Analysis of miRNome Alterations in Response to Sorafenib Treatment in Colorectal Cancer Cells.
Pehserl AM; Ress AL; Stanzer S; Resel M; Karbiener M; Stadelmeyer E; Stiegelbauer V; Gerger A; Mayr C; Scheideler M; Hutterer GC; Bauernhofer T; Kiesslich T; Pichler M
Int J Mol Sci; 2016 Dec; 17(12):. PubMed ID: 27916938
[TBL] [Abstract][Full Text] [Related]
34. MicroRNAs that regulate PTEN as potential biomarkers in colorectal cancer: a systematic review.
Liu J; Ke F; Chen T; Zhou Q; Weng L; Tan J; Shen W; Li L; Zhou J; Xu C; Cheng H; Zhou J
J Cancer Res Clin Oncol; 2020 Apr; 146(4):809-820. PubMed ID: 32146564
[TBL] [Abstract][Full Text] [Related]
35. Meta-analysis of the differentially expressed colorectal cancer-related microRNA expression profiles.
Li HG; Zhao LH; Bao XB; Sun PC; Zhai BP
Eur Rev Med Pharmacol Sci; 2014; 18(14):2048-57. PubMed ID: 25027346
[TBL] [Abstract][Full Text] [Related]
36. Global and targeted circulating microRNA profiling of colorectal adenoma and colorectal cancer.
Zhang J; Raju GS; Chang DW; Lin SH; Chen Z; Wu X
Cancer; 2018 Feb; 124(4):785-796. PubMed ID: 29112225
[TBL] [Abstract][Full Text] [Related]
37. Circulating miRNAs miR-34a and miR-150 associated with colorectal cancer progression.
Aherne ST; Madden SF; Hughes DJ; Pardini B; Naccarati A; Levy M; Vodicka P; Neary P; Dowling P; Clynes M
BMC Cancer; 2015 Apr; 15():329. PubMed ID: 25924769
[TBL] [Abstract][Full Text] [Related]
38. Expression of circulating microRNA-20a and let-7a in esophageal squamous cell carcinoma.
He FC; Meng WW; Qu YH; Zhou MX; He J; Lv P; Ming L
World J Gastroenterol; 2015 Apr; 21(15):4660-5. PubMed ID: 25914476
[TBL] [Abstract][Full Text] [Related]
39. SOX9, miR-495, miR-590-3p, and miR-320d were identified as chemoradiotherapy-sensitive genes and miRNAs in colorectal cancer patients based on a microarray dataset.
Du B; Wang T; Yang X; Wang J; Shi X; Wang X; Wu D; Feng L; Chen L; Zhang W
Neoplasma; 2019 Jan; 66(1):8-19. PubMed ID: 30509082
[TBL] [Abstract][Full Text] [Related]
40. MicroRNA-133b is regulated by TAp63 while no gene mutation is present in colorectal cancer.
Chen Y; Zhang Y; He J; Fu Y; Lin C; Li X
Oncol Rep; 2017 Mar; 37(3):1646-1652. PubMed ID: 28098895
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]